✦ LIBER ✦

Phase II study of Topotecan (TC) in patients (pts) with pretreated small-cell lung cancer (SCLC)

✍ Scribed by Tvede, K.; Ardizzoni, A.; Dombemowsky, P.; Postmus, P.; Buitenhuis, M.; Wanders, J.; van Zandwijk, N.; Krebs, J.B.; Verweij, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of topotecan (TOP) for re

✍ Ogawara, M; Negoro, S; Nishiwaki, Y; Fukuoka, M; Watanabe, K; Niitani, H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Randomised Phase II study of topotecan/c

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

222 Phase II trial of topotecan for smal

✍ Watanabe, K.; Fukuoka, M.; Niitani, H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase II study of topotecan in patients

✍ Perez-Soler, R; Glisson, BS; Kane, J; Raber, MN; Hong, WK 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 157 KB

84 Phase II study of topotecan in refrac

✍ A. Ardizzoni; H.H. Hansen; P. Dombernowsky; S. Kaplan; P.E. Postmus; T. Gamucci; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Phase II studies of topotecan in patient

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 132 KB